在血液透析 (HD) 中患有急性损伤的患者中,万科米辛的使用和AUC/MIC:随机临床试验
Welder Zamoner1,2, Ricardo de Souza Cavalcante3,4, André Luis Balbi5,4
1Internal Medicine Department - Nephrology, Botucatu School of Medicine, University São Paulo State-UNESP, District of Rubiao Junior, Botucatu, Sao Paulo, Brazil. welder.zamoner@unesp.br.
Scientific reports
|December 29, 2024
概括
在血液透析 (HD) 期间的万科米辛剂量需要调整,以保持急性损伤 (AKI) 严重病患者的治疗水平. 在HD疗程中服用万科米辛,特别是2小时的输液,可以改善药物度的频率,并防止亚治疗水平.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 关键护理医学 关键护理医学
背景情况:
- 范科米辛的药理动力学和药理动力学在血液透析 (HD) 过程中发生变化,冒着亚治疗性药物度的风险.
- 患有急性损伤 (AKI) 的重症患者经历了HD,需要仔细管理万科米辛,以确保足够的抗菌药物覆盖.
研究的目的:
- 为了评估在传统和长期的HD疗程期间和之后的万科米辛度.
- 确定预防HD的AKI患者中亚治疗性万科米辛水平的策略.
主要方法:
- 一项随机临床试验,涉及严重病情严重的成年人,在常规 (4小时) 和长期 (6小时和10小时) HD.
- 患者接受了三种治疗方案:控制 (HD后剂量),HD期间的2小时输液或连续24小时输液.
- 在对照组,2小时干预组和持续输液组中分析了174次高频繁症治疗.
主要成果:
- 与对照组相比,干预组显示治疗性万科米辛度的频率明显高 (p < 0.002).
- 最初的万科米辛度是非治疗水平的风险因素 (OR 1.16,p = 0.001).
- 两小时的HD内输液出现了作为一种保护因素,防止亚治疗度 (OR 0.24,p = 0.04).
结论:
- 在HD疗程中服用万科米辛可以防止超出治疗目标的度.
- 2小时的HD内输液策略显著改善了治疗度的频率.
- 需要进行进一步的研究,以优化在透析中的AKI患者的万科米辛剂量,并评估临床结果.
相关概念视频
01:11Renal Failure: Dose Adjustments
34
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
34
01:17Factors Affecting Renal Clearance: Renal Impairment
30
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
30
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
113
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
113
01:27Dialysis
225
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
225
01:06Renal Drug Clearance: Overview
61
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
61
01:09Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
55
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
55